Blanche Mavromatis is an Oncologist in Cumberland, Maryland. Dr. Mavromatis is rated as a Distinguished provider by MediFind in the treatment of Inflammatory Breast Cancer. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Chronic Lymphocytic Leukemia (CLL), and Richter Syndrome. Dr. Mavromatis is currently accepting new patients.

Kristen Fernandez is a General Surgeon in Baltimore, Maryland. Dr. Fernandez is rated as an Advanced provider by MediFind in the treatment of Inflammatory Breast Cancer. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Angiosarcoma, Intraductal Papilloma, and Lymphadenectomy. Dr. Fernandez is currently accepting new patients.

Theodore Tsangaris is a General Surgeon in Prince Frederick, Maryland. Dr. Tsangaris is rated as an Advanced provider by MediFind in the treatment of Inflammatory Breast Cancer. His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Intraductal Papilloma, Mastectomy, and Lymphadenectomy. Dr. Tsangaris is currently accepting new patients.

Md Siddiqui is a Hematologist Oncology specialist and a Hematologist in Salisbury, Maryland. Dr. Siddiqui is rated as an Advanced provider by MediFind in the treatment of Inflammatory Breast Cancer. His top areas of expertise are Pulmonary Embolism, Inflammatory Breast Cancer, Angiosarcoma, and Childhood Iron Deficiency Anemia. Dr. Siddiqui is currently accepting new patients.

Surupa Sen Gupta is a General Surgeon and a Surgical Oncologist in Bethesda, Maryland. Dr. Sen Gupta is rated as an Advanced provider by MediFind in the treatment of Inflammatory Breast Cancer. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Intraductal Papilloma, and Giant Mammary Hamartoma. Dr. Sen Gupta is currently accepting new patients.

Dr. Santa-Maria completed his oncology training at Johns Hopkins, and has been focused on caring for patients with breast cancer since then. He works as both a primary oncologist and consultant for patients with all types and stages of breast cancer. His research interest is in developing new types of treatment for patients with breast cancer using immunotherapy. Dr. Santa is rated as a Distinguished provider by MediFind in the treatment of Inflammatory Breast Cancer. His top areas of expertise are Breast Cancer, Triple-Negative Breast Cancer, Inflammatory Breast Cancer, and Paget Disease of the Breast.

Dr. Antonio Wolff is internationally recognized for his work on breast cancer biomarkers, including HER2. As a practicing oncologist and clinical translational researcher, his research has been pivotal to improve the quality of breast cancer biomarker testing in breast cancer, including HER2 and estrogen receptor testing. Among his leadership accomplishments is ensuring that sophisticated laboratory findings are translated into improved clinical care in breast cancer. He is a Fellow of the American Society of Clinical Oncology (ASCO), a Komen Scholar and a Breast Cancer Research Foundation investigator. He has served as associate editor for Journal of Clinical Oncology, and serves on the National Comprehensive Cancer Network (NCCN) Guideline Steering Committee. He is a leader of the Translational Breast Cancer Research Consortium (TBCRC), and one of the principal investigators of the Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies (EVOLVE) in Metastatic Breast Cancer, which was one of the three disease groups recently awarded by ARPA-H to conduct innovative trials using Advanced Analysis for Precision Cancer Therapy (ADAPT). After many years of service as Breast Committee Chair in the ECOG-ACRIN Clinical Trial Network of the National Cancer Institute (NCI), he was elected in 2024 as Co-Chair of the NCI Breast Cancer Steering Committee and appointed to the international steering committee of the Oxford Overview Collaborative, which are positions aimed at advancing clinical trials in breast cancer. At Johns Hopkins, he is an elected member of the Miller Coulson Academy of Clinical Excellence and was honored during the 125th Anniversary Living the Hopkins Mission celebrations of the JHU School of Medicine. Dr. Wolff is rated as a Distinguished provider by MediFind in the treatment of Inflammatory Breast Cancer. His top areas of expertise are Breast Cancer, HER-2 Positive Breast Cancer, Triple-Negative Breast Cancer, and Inflammatory Breast Cancer.

"Pamela A. Wright, M.D., is a breast surgeon with Johns Hopkins Community Physicians and the medical director of the Suburban Hospital Breast Center. Dr. Wright's expertise is in surgical oncology for breast cancer, including breast conserving surgery and sentinel lymph node biopsy. She also has expertise in benign breast disease and breast biopsy, including stereotactic and ultrasound-guided biopsy. Dr. Wright earned her Master of Science in Anatomy and her medical degree from University of Maryland School of Medicine. She completed a residency in general surgery at University of Maryland Medical Center, where she served as chief resident and administrative chief resident. Dr. Wright also completed a trauma research fellowship with the National Institutes of Health. Dr. Wright serves as the cancer liaison physician for the American College of Surgeons, of which she is also a fellow. Dr. Wright is also a member of the American Society of Breast Surgeons. Dr. Wright is repeatedly recognized as one of the area’s “Top Doctors in Breast Surgery"" by Washingtonian magazine. She has also received the Cancer Liaison Physician Outstanding Performance Award and the Health Care Hero Award from the American Cancer Society. Dr. Wright has published research and conducted clinical trials for breast cancer. She currently runs research trials with Suburban Hospital Oncology Research.". Dr. Wright is rated as a Distinguished provider by MediFind in the treatment of Inflammatory Breast Cancer. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, Angiosarcoma, and Lymphadenectomy.

Dr. Susan Bahl, MD, FACS, is a distinguished Breast Surgeon who recently joined Johns Hopkins, practicing at both Howard County Medical Center and Johns Hopkins Bayview Medical Center. A strong advocate for women's health, Dr. Bahl brings over a decade of experience in providing state-of-the-art, evidence-based breast care within multidisciplinary settings. She has a passion for delivering personalized treatment plans to patients, specializing in both benign and malignant breast diseases. Before joining Johns Hopkins, Dr. Bahl served as the Medical Director of the Frederick Health Breast Center, where she founded a NAPBC-accredited multidisciplinary breast cancer clinic. In this role, she helped streamline the treatment process for newly diagnosed breast cancer patients by coordinating care between breast surgeons, medical oncologists, and radiation oncologists. Dr. Bahl also co-directed a Breast Screening and Prevention Program designed for high-risk women, integrating genetic testing, risk-reduction surgeries, and chemo-prevention strategies. Her commitment to patient-centered care and leadership in breast health make her a valuable addition to the Johns Hopkins community. Dr. Bahl is rated as a Distinguished provider by MediFind in the treatment of Inflammatory Breast Cancer. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Angiosarcoma, Inflammatory Breast Cancer, and Lymphadenectomy.

Dr. Rima Jean Couzi is a cancer specialist in Towson, Maryland, caring for patients with breast cancer. Dr. Couzi earned her medical degree at the National University of Ireland. She completed residencies at St. Laurence's Hospital/Beaumont Hospitals and Galway Regional in Dublin, as well as Franklin Square Hospital in Baltimore. She performed a fellowship in medical oncology at St. Vincent's Hospital and St. James's Hospital in Dublin, and an additional fellowship in medical oncology at Johns Hopkins Oncology Center in Baltimore. She also earned a master’s degree in clinical epidemiology from the Johns Hopkins Bloomberg School of Public Health. Dr. Couzi joined the Johns Hopkins faculty in 2004. Dr. Couzi is a member of the American Society of Clinical Oncology and the Royal College of Physicians in Ireland. Selected Publications Antonarakis ES, Fradin JM, Petronis JD, Couzi RJ. “Not What It Seems.” Am J Med. 2007;120:408-411 Holdhoff M, Wung PK, Petronis J, Couzi R. “Persistent PET-positive liver lesions after successful chemotherapy in a patient with mediastinal seminoma.” J. Clin Oncol. 2007;25:2482-4. Li S, Couzi RJ, Thomas GH, Friedman AD, Borowitz MJ. “A novel variant three-way translocation of inversion 16 in a case of AML-M4eo following low dose methotrexate therapy.” Cancer Genet Cytogenet. 2001; 125:74-7. Schultz MJ, Tabb RD, Eagan JW, Citron JR, Couzi RJ. “Treating a male breast cancer patient with moderately differentiated, infiltrating ductal cancer of the breast.” Journal of Multidisciplinary Cancer Care. 2009 September – October. Siegelbaum MH, Citron JR, Eagan JW, Couzi RJ. “Treating a patient with Unfavorable-risk prostate cancer.” Journal of Multidisciplinary Cancer Care. 2009; July – August. Dr. Couzi is rated as a Distinguished provider by MediFind in the treatment of Inflammatory Breast Cancer. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Inflammatory Breast Cancer.

Dr. Julie Lange is an assistant professor of surgery, dermatology and oncology at the Johns Hopkins University School of Medicine. Dr. Lange was one of the original members of the Johns Hopkins melanoma group when it was first formed in 1995 and now serves as a clinical co-director of the Melanoma Program. Dr. Lange introduced the sentinel node technique to Johns Hopkins for both melanoma and breast cancer in the 1990s and has extensive experience with this technique. Dr. Lange is a graduate of the Vanderbilt University School of Medicine and completed her general surgery training at Yale-New Haven Hospital. She completed a fellowship in surgical oncology and immunotherapy at the Surgery Branch of the National Cancer Institute as well. Dr. Lange joined the faculty of the Department of Surgery at Johns Hopkins in 1994 and subsequently earned a Sc.M. in clinical investigation at the Johns Hopkins Bloomberg School of Public Health. She has particular interest in melanoma at extremes of age, and in the factors associated with variance in melanoma care. Dr. Lange has published the largest study of melanoma in children, adolescents and young adults. She recognizes that melanoma in the older patient is a growing epidemic and has investigated the socioeconomic, demographic and healthcare factors that influence the treatment of melanoma in older persons. Dr. Lange is a member of the melanoma panel of the National Comprehensive Cancer Network, a group that annually evaluates and revises national treatment guidelines for melanoma. In 2015, she was inducted for her work into the Miller-Coulson Academy of Clinical Excellence, which recognizes outstanding clinicians at Johns Hopkins based on a number of factors, including communication and interpersonal skills, professionalism and humanism, a scholarly approach to clinical practice, and a passion for patient care. Dr. Lange is rated as a Distinguished provider by MediFind in the treatment of Inflammatory Breast Cancer. Her top areas of expertise are Melanoma, Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Lymphadenectomy.

Sandra Swain is a Hematologist Oncology provider in Bethesda, Maryland. Dr. Swain is rated as a Distinguished provider by MediFind in the treatment of Inflammatory Breast Cancer. Her top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, HER-2 Positive Breast Cancer, and Febrile Neutropenia.

Michael Stasko is a General Surgeon in Cumberland, Maryland. Dr. Stasko is rated as an Advanced provider by MediFind in the treatment of Inflammatory Breast Cancer. His top areas of expertise are Chronic Subdural Hematoma, Paget Disease of the Breast, Anorectal Abscess, Lymphadenectomy, and Colostomy. Dr. Stasko is currently accepting new patients.

Roy Chisholm is a General Surgeon in Cumberland, Maryland. Dr. Chisholm is rated as an Advanced provider by MediFind in the treatment of Inflammatory Breast Cancer. His top areas of expertise are Hernia, Cholecystitis, Gallbladder Disease, Bladder Reconstruction, and Colostomy. Dr. Chisholm is currently accepting new patients.

Noeline Rajarajan is a General Surgeon in Baltimore, Maryland. Dr. Rajarajan is rated as an Experienced provider by MediFind in the treatment of Inflammatory Breast Cancer. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Breast Lump, and Intraductal Papilloma. Dr. Rajarajan is currently accepting new patients.

David Riseberg is an Oncologist and a Hematologist in Baltimore, Maryland. Dr. Riseberg is rated as a Distinguished provider by MediFind in the treatment of Inflammatory Breast Cancer. His top areas of expertise are Breast Cancer, Angiosarcoma, Paget Disease of the Breast, and Inflammatory Breast Cancer. Dr. Riseberg is currently accepting new patients.

Gurdeep Chhabra is a Hematologist Oncology specialist and a Hematologist in California, Maryland. Dr. Chhabra is rated as a Distinguished provider by MediFind in the treatment of Inflammatory Breast Cancer. His top areas of expertise are Inflammatory Breast Cancer, Paget Disease of the Breast, Colorectal Cancer, and Small Cell Lung Cancer (SCLC). Dr. Chhabra is currently accepting new patients.

Katherine Tkaczuk is an Oncologist in Baltimore, Maryland. Dr. Tkaczuk is rated as a Distinguished provider by MediFind in the treatment of Inflammatory Breast Cancer. Her top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, Angiosarcoma, and Paget Disease of the Breast. Dr. Tkaczuk is currently accepting new patients.

John Fetting is an Oncologist in Lutherville, Maryland. Dr. Fetting is rated as a Distinguished provider by MediFind in the treatment of Inflammatory Breast Cancer. His top areas of expertise are Breast Cancer, Angiosarcoma, Paget Disease of the Breast, and Inflammatory Breast Cancer.

Rabindra Paul is a Hematologist and an Oncologist in Snow Hill, Maryland. Dr. Paul is rated as a Distinguished provider by MediFind in the treatment of Inflammatory Breast Cancer. His top areas of expertise are Inflammatory Breast Cancer, Colorectal Cancer, Paget Disease of the Breast, Familial Colorectal Cancer, and Bone Marrow Aspiration.